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A B S T R A C T
Owing to new surgical procedures and medications, more women who have undergone the Fontan
procedure reach childbearing ages. We report five cases of pregnancy with Fontan circulation. Case 1 had
subchorionic hematoma (SCH), fetal growth restriction (FGR), and preterm labor (PTL). She delivered a
1073 g infant via cesarean section at gestation week 28 because of hemorrhagic shock. Case 2 delivered
2142 g and 2232 g infants at gestation weeks 37 and 36, respectively. She had FGR, PTL, and postpartum
hemorrhage (PPH). Case 3 had SCH, PTL, and heart failure. At 36 weeks, labor was induced and she
delivered a 2546 g infant by vacuum extraction with epidural analgesia. Cases 4 and 5 resulted in
miscarriage. All subjects experienced obstetrical complications. This report discusses pregnant women
with Fontan circulation by focusing on affected Japanese women.
<Learning objective: More women who have undergone the Fontan procedure reach childbearing ages
due to the new surgical procedures and medications. We report five cases and all of them experienced
obstetrical complications. Anticoagulation might be one of the causes of postpartum hemorrhage. Labor
epidural analgesia could contribute to minimized dynamic circulatory changes during labor. This report
can be the literature regarding pregnant women with Fontan circulation in Japan.>
© 2019 Published by Elsevier Ltd on behalf of Japanese College of Cardiology. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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As a result of surgical procedures and medications, more
women who have undergone the Fontan procedure reach
childbearing ages. Pregnancy after the Fontan procedure carries
one of the highest perinatal risks [1,2] and can result in disorders,
including maternal heart failure, arrhythmia, hypertensive disor-
der of pregnancy, and postpartum hemorrhage. Fetal complica-
tions, such as intrauterine growth retardation, preterm labor, and
low birth weight can also occur. Here, we report five cases of
pregnancy with Fontan circulation in Japan (Table 1).
Case report
Case 1: A 33-year-old primiparous woman with a history of
congenital pulmonary atresia and an intact vertical septum* Corresponding author at: Department of Obstetrics and Gynecology, Okayama
University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,
2-5-1 Shikata, Okayama 700-8558, Japan.
E-mail address: eeto@okayama-u.ac.jp (E. Eto).
https://doi.org/10.1016/j.jccase.2019.12.005
1878-5409/© 2019 Published by Elsevier Ltd on behalf of Japanese College of Card
creativecommons.org/licenses/by-nc-nd/4.0/).presented to our hospital at 5 weeks of gestation. She had
undergone the Fontan operation with an atriopulmonary
connection (APC), an extracardiac total cavopulmonary connection
(TCPC), and pacemaker implantation for a postoperative complete
atrioventricular block with syncopal and vertiginous episodes.
Her preconception brain natriuretic peptide (BNP) level was
38.8 pg/mL with a New York Heart Association (NYHA) class II
functional status. Furosemide, spironolactone, hydrochlorothia-
zide, pilsicainide hydrochloride, and warfarin 4 mg per day were
administered regularly. At conception, warfarin was replaced with
unfractionated heparin (UFH) and acetylsalicylic acid, and
pilsicainide hydrochloride was replaced with digoxin. The patient
was admitted for massive genital bleeding due to subchorionic
hemorrhage at 11 weeks gestation. The dose of UFH was 10,000 U
per day and activated partial thromboplastin time (APTT) value
was 47.5 s. When the bleeding began to decrease, heparin was
replaced with danaparoid sodium. The dose of danaparoid was
1250 U per day. BNP levels were relatively elevated during the
pregnancy, sometimes over 100 pg/mL, while ultrasound indicated
that there was no considerable change in cardiac ejection fraction.
At 28 weeks of gestation, the patient experienced hemorrhagiciology. This is an open access article under the CC BY-NC-ND license (http://
Table 1 Summary of six cases.
Case Age of
patient
(years)
Cardiac
complications
Gestational
age at
delivery
(weeks)
Mode of
delivery
Perinatal
complications
Weight of
neonate (g)
Medical
complication
MaximumBNP
during pregnancy
(pg/mL)
EF at
delivery (%)
1 33 Complete AVB
Mild MR
Pace maler
29 C-section PTL, FGR, SGA, SCH, PPH 1073 Ascites, CHF 100.8 68
2-1 30 Mild TR
Moderate TR
37 Vaginal delivery,Vacuum FGR, SGA, PPH 2142 – 55.2 60
2-2 33 Mild TR
Mild MR
36 Vaginal delivery PTL, FGR, SGA, PPH 2232 – 46.1 58
3 28 Moderate AVVR
Trivial AR
36 Vaginal delivery, Vacuum HDP, PTL, SCH 2546 Heart failure 466 40
4 25 PSVT
Moderate AVVR
14 Miscarriage SCH, IUFD – Worse PSVT 135.5
5 38 SSS
Mild MR
Pace maker
10 Miscarriage IUFD – – 15.1
BNP, brain natriuretic peptide; EF, ejection fraction; AVB, atrioventricular block; MR, mitral regurgitation; TR, tricuspid regurgitation; AVVR, atrioventricular regurgitation;
AR, aortic regurgitation; PSVT, paroxysmal supraventricular tachycardia; SSS, sick sinus syndrome; HDP, hypertensive disorders; PTL, preterm labor; FGR, fetal growth
restriction; SGA, small for gestational age; SCH, subchorionic hematoma; PPH, postpartum hemorrhage; IUFD, intrauterine fetal death, CHF, chronic heart failure; C-section,
Cesarean section.
E. Eto et al. / Journal of Cardiology Cases 21 (2020) 161–163162shock and imaging revealed the growth of a subchorionic
hematoma. On that day, cesarean section was performed under
general anesthesia. The volume of blood loss during the cesarean
section was 1070 mL. The patient had a good postoperative course
and resumed danaparoid sodium and warfarin on the third day
following the procedure.
Case 2-1: A 31-year-old primiparous woman presented to our
hospital at 6 weeks of gestation. She had undergone the Blalock–
Taussig operation for a double inlet left ventricle at age 2 years,
the Fontan procedure with an APC at age 12 years, and TCPC at age
27 years. Her BNP level was 29.9 pg/mL before conception and her
NYHA functional status was class II. Furosemide, spironolactone,
and warfarin 3.5 mg per day were administered regularly.
Warfarin was replaced with UFH at conception and resumed at
15 weeks of gestation. She had a good perinatal course. She was
admitted to our hospital at 36 weeks gestation for continuous
intravenous heparin therapy to replace warfarin. During labor
induction, which was started at 37 weeks, a central venous
indwelling catheter was inserted to check the vital signs. She was
delivered of her baby by vacuum. The volume of blood loss during
labor was 1000 mL. Intrapartum central venous pressure
remained below 15 mmHg. The patient had no episode of
arrhythmia during the pregnancy and labor, and she had a good
postpartum course.
Case 2-2: This is the same patient of Case 2-1. After 2 years had
passed, she had a good perinatal course and BNP levels ranged
between 10 and 50 pg/mL. She was admitted at 36 weeks to start
continuous intravenous heparin instead of warfarin. Labor started
at 36 weeks and 4 days of gestation. A central venous catheter was
placed. She was delivered an infant by vacuum extraction. The
volume of blood loss during labor was 1000 mL. Intrapartum
central venous pressure remained below 20 mmHg. She had a good
postpartum course.
Case 3: A 28-year-old primiparous woman was admitted to our
hospital at 5 weeks of gestation. She had undergone an aortopul-
monary shunt operation at age 2 years, a bidirectional Glenn shunt
operation due to a double inlet right ventricle at age 9 years, and the
Fontan procedure with TCPC at age 14 years. Her preconception BNP
level was 18.3 pg/mL, with a NYHA class II functional status. She had
been administered aspirin regularly and it was substituted with
apixaban from 15 weeks of gestation. She was admitted for face and
legedema, 6 kg weight gain for 2 weeks, and proteinuria at 35 weeks.
Her blood pressure was 145/90 mmHg. Chest radiography revealedthe enlarged cardiothoracic ratio of 50% and pleural effusion and that
her BNP level had risen to 466 pg/mL. We started furosemide,
spironolactone, and continuous intravenous heparin administration
to replace apixaban. At 36 weeks, labor was induced. Epidural
analgesia catheter was inserted 6 h after stopping heparin. She was
placed supine with left uterine displacement. Fentanyl 25 mg was
injected intrathecally. The first stage of labor was 7 h and 30 min, and
the second stage of labor was 2 h and 54 min. Avoiding the labor
effort, we used vacuum extraction to shorten the time of second
stage. The blood loss during labor was 300 mL. The patient had no
episode of arrhythmia during the pregnancy and labor. Her heart
failure had improved, and her BNP level was 28.4 pg/mL at 2 weeks
postpartum.
Case 4: A 25-year-old primiparous woman was admitted to our
hospital at 5 weeks of gestation. She had undergone the Blalock–
Taussig operation for a double inlet left ventricle at 1 month, the
Fontan procedure at age 6 years. Paroxysmal supraventricular
tachycardia (PSVT) appeared at the age of 20 years. She was taking
antiarrhythmic therapy with propafenone hydrochloride, verapa-
mil hydrochloride, and perindopril erbumine which was stopped
at conception. She also took atenolol. PSVT begun to occur
frequently after conception. Rivaroxaban was replaced with UFH.
She had miscarriage at 14 weeks of gestation.
Case 5: A 25-year-old primiparous woman was admitted to our
hospital at 5 weeks of gestation. She had undergone the Fontan
operation and pacemaker implantation for a postoperative sick
sinus syndrome. Warfarin 2.5 mg per day was replaced with UFH.
She had miscarriage at 10 weeks of gestation.
Discussion
Our report shows high perinatal risks in pregnant women with
Fontan circulation. Recently, there were some studies reporting
successful pregnancies with Fontan palliation [3,4].
We experienced postpartum hemorrhage (PPH) in Cases 1, 2-1,
and 2-2. Blood loss of 500 mL for vaginal delivery and 1000 mL
for cesarean section is classified as PPH. A previous study reported
that women with a Fontan circulation were most prone to PPH
[5]. Regarding anticoagulation, the advice is to stop taking low
molecular weight heparin (LMWH) at first stage of labor and omit
administration for at least 12 h (preventive) or 24 h (therapeutic)
until delivery. On the other hand, another study reported pregnant
women with therapeutic LMWH had a greater risk of PPH despite
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usually replaced with UFH at conception and resumed at 15 weeks
of gestation. UFH is started at 10,000 U per day and adjusted the
dose to keep the APTT level ranged from 50 to 80 s. After 36 weeks
of gestation, warfarin is replaced with UFH again. Heparin is
stopped 6 h before starting induction of labor. Although there is a
possibility that anticoagulation is one of the causes for PPH,
anticoagulation is important therapy for thromboembolic disease
and valve thrombosis which are causes of maternal mortality. It
remains a great issue whether the anticoagulant therapy is
necessary or not for people with Fontan circulation.
Labor epidural analgesia could contribute to minimized
dynamic circulatory changes during labor in patients with
congenital heart disease. In case 3, the patient could avoid effort
in the second stage of labor and stabilize circulation dynamics.
There are several studies on the successful use of labor epidural
analgesia for congenital heart disease [7,8]. The diminished venous
return was prevented by avoiding the labor effort. Adequate pain
relief with minor hemodynamic changes prevented tachycardia
and hypertension. In case 2-1 and 2-2, epidural anesthesia had
been planned but not been used because labor progressed rapidly.
Further research is required to assess the effect of labor analgesia.
Some drugs, for example, diuretics, antiarrhythmic drugs, and
anticoagulants are administered only when it is judged that the
therapeutic benefits outweigh the risks during pregnancy. In all
cases, the drugs administered before pregnancy were essential for
the maternal treatment during pregnancy. That is why we
continued the therapy to keep maternal cardiac condition stable.
There are few reports of pregnancy with Fontan circulation. It is
important to recognize the individual risks associated with
pregnancy in women with Fontan circulation. This report can bethe literature regarding pregnant women with Fontan circulation
by focusing on affected Japanese women.
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